Mural Oncology PLCNASDAQ:MURA
- LAST PRICE3.3700
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots3.2700/ 10
- Ask / Lots4.0100/ 100
- Open / Previous Close--- / 3.3700
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MURA |
|---|---|---|
| 09:44 ET | 100 | 3.39 |
| 09:53 ET | 200 | 3.345 |
| 10:13 ET | 200 | 3.36 |
| 10:18 ET | 2500 | 3.311 |
| 10:22 ET | 488 | 3.36 |
| 10:31 ET | 408 | 3.35 |
| 10:33 ET | 146 | 3.36 |
| 10:42 ET | 1099 | 3.3612 |
| 10:44 ET | 100 | 3.37 |
| 10:45 ET | 450 | 3.38 |
| 10:47 ET | 100 | 3.41 |
| 10:56 ET | 500 | 3.4 |
| 11:02 ET | 600 | 3.41 |
| 11:05 ET | 100 | 3.39 |
| 11:12 ET | 577 | 3.38 |
| 11:14 ET | 447 | 3.38 |
| 11:21 ET | 466 | 3.38 |
| 11:25 ET | 1000 | 3.39 |
| 11:30 ET | 533 | 3.41 |
| 11:36 ET | 100 | 3.41 |
| 11:41 ET | 200 | 3.4201 |
| 11:43 ET | 100 | 3.4 |
| 11:45 ET | 434 | 3.389371 |
| 11:48 ET | 2100 | 3.38 |
| 11:50 ET | 1400 | 3.385 |
| 11:57 ET | 100 | 3.4 |
| 12:15 ET | 300 | 3.39 |
| 12:19 ET | 398 | 3.39 |
| 12:35 ET | 300 | 3.38 |
| 12:42 ET | 1478 | 3.365 |
| 12:44 ET | 100 | 3.3834 |
| 01:06 ET | 1000 | 3.38 |
| 01:08 ET | 150 | 3.3837 |
| 01:09 ET | 700 | 3.38 |
| 01:18 ET | 200 | 3.38 |
| 01:33 ET | 400 | 3.38 |
| 01:42 ET | 500 | 3.38 |
| 01:47 ET | 628 | 3.38 |
| 01:49 ET | 450 | 3.38 |
| 01:51 ET | 333 | 3.38 |
| 01:54 ET | 700 | 3.38 |
| 02:02 ET | 600 | 3.38 |
| 02:12 ET | 1300 | 3.38 |
| 02:14 ET | 870 | 3.38 |
| 02:20 ET | 600 | 3.38 |
| 02:32 ET | 1464 | 3.37 |
| 02:34 ET | 1000 | 3.3848 |
| 02:38 ET | 1700 | 3.38 |
| 02:39 ET | 1777 | 3.3828 |
| 02:43 ET | 585 | 3.375 |
| 02:45 ET | 3360 | 3.38 |
| 02:48 ET | 661 | 3.39 |
| 02:50 ET | 1295 | 3.38 |
| 02:52 ET | 577 | 3.38 |
| 02:54 ET | 940 | 3.38 |
| 02:56 ET | 714 | 3.37 |
| 02:57 ET | 892 | 3.38 |
| 02:59 ET | 100 | 3.38 |
| 03:01 ET | 1005 | 3.38 |
| 03:03 ET | 129 | 3.38 |
| 03:06 ET | 435 | 3.38 |
| 03:08 ET | 1254 | 3.38 |
| 03:10 ET | 447 | 3.38 |
| 03:12 ET | 661 | 3.38 |
| 03:14 ET | 632 | 3.375 |
| 03:15 ET | 600 | 3.37 |
| 03:17 ET | 133 | 3.38 |
| 03:19 ET | 362 | 3.38 |
| 03:21 ET | 2213 | 3.385 |
| 03:24 ET | 799 | 3.38 |
| 03:26 ET | 239 | 3.38 |
| 03:28 ET | 301 | 3.38 |
| 03:30 ET | 200 | 3.38 |
| 03:32 ET | 689 | 3.38 |
| 03:33 ET | 10072 | 3.26 |
| 03:35 ET | 4425 | 3.2701 |
| 03:37 ET | 2137 | 3.32 |
| 03:39 ET | 633 | 3.34 |
| 03:42 ET | 300 | 3.355 |
| 03:46 ET | 100 | 3.36 |
| 03:48 ET | 2508 | 3.33 |
| 03:53 ET | 300 | 3.3387 |
| 03:55 ET | 500 | 3.34 |
| 03:57 ET | 1296 | 3.34 |
| 04:00 ET | 17623 | 3.37 |
Nov 20, 2024
Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown in its ARTISTRY-1 Clinical Trial of Nemvaleukin, its Lead Engineered Fusion Protein, in the Journal for ImmunoTherapy of Cancer, from 4:15PM ET on Wednesday Nov 20, 2024 by Dow Jones
4:15PM ET on Wednesday Nov 20, 2024 by Dow Jones
Nov 14, 2024
DJ Mural Oncology Price Target Maintained With a $18.00/Share by HC Wainwright & Co., from 5:00AM ET on Thursday Nov 14, 2024 by Dow Jones
5:00AM ET on Thursday Nov 14, 2024 by Dow Jones
Nov 13, 2024
Mural Oncology Announces Third Quarter 2024 Financial Results and Provides Update on Pipeline Progress, from 7:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
7:00AM ET on Wednesday Nov 13, 2024 by Dow JonesPress Release: Mural Oncology Announces Third Quarter 2024 Financial Results and Provides Update on Pipeline Progress, from 7:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
7:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
Nov 11, 2024
Mural Oncology to Participate in Two Upcoming Investor Conferences, from 7:00AM ET on Monday Nov 11, 2024 by Dow Jones
7:00AM ET on Monday Nov 11, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Mural Oncology PLC | 57.4M | -0.4x | --- |
Boundless Bio Inc | 57.3M | -0.9x | --- |
enVVeno Medical Corp | 57.9M | -2.5x | --- |
Aileron Therapeutics Inc | 55.9M | -0.8x | --- |
BioVie Inc | 55.2M | -0.5x | --- |
Entera Bio Ltd | 59.7M | -6.2x | --- |
Company Information
Mural Oncology plc is Ireland-based clinical-stage oncology company. The Company is leveraging its protein engineering platform to develop cytokine-based immunotherapies for the treatment of cancer. It leverages its in-cytokine biology, immune cell modulation and protein engineering capabilities to develop immunotherapies. The Company is developing a portfolio of programs to broaden the potential and reach of cytokine-based immunotherapies for the treatment of cancers, particularly those with limited treatment options available. Its portfolio of programs includes Nemvaleukin alfa (Nemvaleukin)-IL-2, IL-12, and IL-18. Nemvaleukin is an engineered interleukin-2 (IL-2) variant designed to harness the potent anti-cancer capabilities of high-dose rhIL-2 while minimizing toxicity by selectively activating cancer-fighting CD8 T cells and NK cells. The tumor-targeted split IL-12 program focuses on delivering the therapeutic potential of IL-12 by splitting it into inactive component.
Contact Information
- Headquarters
- 10 Earlsfort TerraceDUBLIN, Ireland D02 T380
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Scott Jackson
- President, Chief Executive Officer, Director
- Caroline Loew
- Chief Financial Officer
- Adam Cutler
- Chief Medical Officer
- Vicki Goodman
- Chief Legal Officer
- Maiken Keson-Brookes
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $57.4M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 17.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-9.14 |
Book Value | $15.81 |
P/E Ratio | -0.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
